Skip to content

Viking Therapeutics VKTX Invested capital

Discontinued — last reported Q4 '25

Invested capital at other companies

Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
Power Integrations logo
Power IntegrationsPOWI
1.5%-1.0pp
SSR Mining logo
SSR MiningSSRM
18.7%
Repligen logo
RepligenRGEN
0.3%-6.3pp
MYR Group logo
MYR GroupMYRG
18.4%+13.4pp

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$4.04B+38.7%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Calculated from Viking Therapeutics’s reported figures.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's invested capital?
Viking Therapeutics (VKTX) reported invested capital of $473.39M in Q4 2025.
How has Viking Therapeutics's invested capital changed year-over-year?
Viking Therapeutics's invested capital decreased by 44.6% year-over-year, from $854.72M to $473.39M.
What is the long-term trend for Viking Therapeutics's invested capital?
Over 5 years (2020 to 2025), Viking Therapeutics's invested capital has grown at a 17.0% compound annual growth rate (CAGR), from $215.59M to $473.39M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).